Published in Eur J Nucl Med Mol Imaging on September 23, 2004
Increased rate of dicentric chromosomes in French Polynesian thyroid cancer patients? Eur J Nucl Med Mol Imaging (2006) 0.75
Cytogenetic biodosimetry and dose-rate effect after radioiodine therapy for thyroid cancer. Radiat Environ Biophys (2017) 0.75
IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res (2000) 2.14
Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res (2000) 1.97
Genotoxicity of pesticides: a review of human biomonitoring studies. Mutat Res (2003) 1.71
Radiation-induced chromosome aberrations in nuclear-dockyard workers. Nature (1979) 1.43
Epidemiology and primary prevention of thyroid cancer. Thyroid (2002) 1.41
Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis (2004) 1.28
Chromosomal aberrations: formation, identification and distribution. Mutat Res (2002) 1.22
The incidence of unstable chromosome aberrations in peripheral blood lymphocytes from unirradiated and occupationally exposed people. Mutat Res (1980) 1.02
In vivo and in vitro effects of cigarette smoke on chromosomal damage and sister-chromatid exchange in human peripheral blood lymphocytes. Mutat Res (1982) 1.00
Quantification of low-level radiation exposure by conventional chromosome aberration analysis. Mutat Res (1995) 0.91
Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974. Cancer Causes Control (2000) 0.87
Cytogenetic analysis of peripheral blood lymphocytes of occupational workers exposed to low levels of ionising radiation. Mutat Res (1999) 0.87
Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med (1996) 0.84
Chromosome aberrations (CA), sister-chromatid exchanges (SCE) and mitogen-induced blastogenesis in cultured peripheral lymphocytes from 48 control individuals sampled 8 times over 2 years. Mutat Res (1991) 0.84
Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med (1997) 0.82
Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res (2000) 0.82
The 60Co gamma ray dose-response for chromosomal aberrations in human lymphocytes analysed by FISH; applicability to biological dosimetry. Int J Radiat Biol (1999) 0.82
Risk estimation based on chromosomal aberrations induced by radiation. Radiat Res (2001) 0.81
Cytogenetic analyses by fluorescence in situ hybridization (FISH) in hospital workers occupationally exposed to low levels of ionizing radiation. Radiat Res (2001) 0.81
Analysis of chromosome aberrations in lymphocytes of long-term heavy smokers. Mutat Res (1986) 0.80
Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res (1994) 0.78
Frequencies of chromosomal aberrations in smokers exposed to pesticides in cotton fields. Mutat Res (1989) 0.76
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma. J Clin Endocrinol Metab (1986) 2.70
Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer (1998) 2.57
Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10
BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood (2001) 1.90
Radiation and genetic factors in the risk of second malignant neoplasms after a first cancer in childhood. Lancet (1997) 1.84
Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med (1996) 1.77
Long-term risk of sarcoma following radiation treatment for breast cancer. Int J Radiat Oncol Biol Phys (1991) 1.77
Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer (1985) 1.66
Can internal mammary chain treatment decrease the risk of death for patients with medial breast cancers and positive axillary lymph nodes? Cancer (1990) 1.55
Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med (1996) 1.49
Presence of mutations in all three ras genes in human thyroid tumors. Oncogene (1990) 1.42
Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia. Int J Radiat Biol (1995) 1.38
gsp mutations in human thyroid tumours. Oncogene (1991) 1.37
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood. Int J Cancer (1998) 1.32
Leukaemia mortality in French communes (administrative units) with a large and rapid population increase. Br J Cancer (1994) 1.29
Radiation dose, chemotherapy, hormonal treatment and risk of second cancer after breast cancer treatment. Br J Cancer (2003) 1.29
Cardiac abnormalities 15 years and more after adriamycin therapy in 229 childhood survivors of a solid tumour at the Institut Gustave Roussy. Br J Cancer (2004) 1.29
gamma-Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med (1998) 1.26
Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen. Br Med J (Clin Res Ed) (1982) 1.25
Risks of brain tumour following treatment for cancer in childhood: modification by genetic factors, radiotherapy and chemotherapy. Int J Cancer (1998) 1.17
Detection of activated ras oncogenes in human thyroid carcinomas. Oncogene (1988) 1.12
Estimation of the radiation dose delivered to any point outside the target volume per patient treated with external beam radiotherapy. Radiother Oncol (1996) 1.12
Increased risk of second cancers following breast cancer: role of the initial treatment. Breast Cancer Res Treat (2000) 1.09
A single amino-acid substitution in the Ets domain alters core DNA binding specificity of Ets1 to that of the related transcription factors Elf1 and E74. Nucleic Acids Res (1993) 1.07
Diet, living conditions and nasopharyngeal carcinoma in Tunisia--a case-control study. Int J Cancer (1990) 1.06
Differentiated thyroid carcinoma in childhood: long term follow-up of 72 patients. J Clin Endocrinol Metab (1987) 1.05
Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institut Gustave-Roussy. Tumori (1990) 1.04
Characterization and radiosensitivity at high or low dose rate of four cell lines derived from human thyroid tumors. Int J Radiat Oncol Biol Phys (1997) 1.02
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma. J Nucl Med (1996) 1.02
5-Fluorouracil, doxorubicin, and cisplatin regimen in adrenal cortical carcinoma. Cancer (1988) 0.99
Combination of radioiodine (131I) and probe-guided surgery for persistent or recurrent thyroid carcinoma. J Clin Endocrinol Metab (1998) 0.98
[Epithelioma of the thyroid secreting thyrocalcitonin]. C R Acad Sci Hebd Seances Acad Sci D (1968) 0.98
Combination therapy for anaplastic giant cell thyroid carcinoma. Cancer (1991) 0.96
Undifferentiated carcinoma of nasopharyngeal type of tonsil. Arch Otolaryngol Head Neck Surg (1989) 0.93
Refining interpretation of MIBG scans in children. J Nucl Med (1994) 0.93
Leukaemias and cancers following iodine-131 administration for thyroid cancer. Br J Cancer (1997) 0.92
Combined hormone replacement therapy and risk of breast cancer in a French cohort study of 3175 women. Climacteric (2002) 0.92
Reinvestigation of the proteolytic activity of neocarzinostatin. J Bacteriol (2000) 0.90
Circulating thyroglobulin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relationship to serum thyrotropin levels. J Clin Endocrinol Metab (1980) 0.90
Medullary thyroid carcinoma: prognostic factors and treatment. Int J Radiat Oncol Biol Phys (1983) 0.90
Detection and treatment of lung metastases of differentiated thyroid carcinoma in patients with normal chest X-rays. J Nucl Med (1988) 0.90
Comparison of radiolabeled octreotide and meta-iodobenzylguanidine (MIBG) scintigraphy in malignant pheochromocytoma. J Nucl Med (1995) 0.89
Medullary carcinoma and thyrocalcitonin. Br Med J (1968) 0.88
Cancer registry of French Polynesia: results for the 1990-1995 period among native and immigrant population. Eur J Epidemiol (2000) 0.88
Multiple molecular mechanisms contribute to radiation sensitivity in mantle cell lymphoma. Oncogene (2003) 0.87
Value of venous catheterization and calcitonin studies in the treatment and management of clinically inapparent medullary thyroid carcinoma. Cancer (1989) 0.87
Radiation dose as a risk factor for malignant melanoma following childhood cancer. Eur J Cancer (2003) 0.86
Structure and expression of c-myc and c-fos proto-oncogenes in thyroid carcinomas. Br J Cancer (1988) 0.86
Irradiation and second cancers. The thyroid as a case in point. C R Acad Sci III (1999) 0.86
Blastoid mantle cell lymphoma: evidence for nonrandom cytogenetic abnormalities additional to t(11;14) and generation of a mouse model. Cancer Genet Cytogenet (2003) 0.86
Thyroglobulin measurement and postablative iodine-131 total body scan after total thyroidectomy for differentiated thyroid carcinoma in patients with no evidence of disease. Eur J Cancer (1996) 0.85
Premature chromosome condensation associated with fluorescence in situ hybridisation detects cytogenetic abnormalities after a CT scan: evaluaton of the low-dose effect. Radiat Prot Dosimetry (2003) 0.85
Iodine 131 uptake in a pleuropericardial cyst: case report of a false-positive radioiodine total body scan result in a patient with a thyroid cancer. Eur J Nucl Med (1991) 0.85
Selective venous sampling catheterisation for localisation of persisting medullary thyroid carcinoma. Br J Cancer (1994) 0.85
Construction and clinical validation of a sensitive and specific assay for serum mature calcitonin using monoclonal anti-peptide antibodies. Clin Chim Acta (1988) 0.85
Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med (1996) 0.84
Internal motions of apo-neocarzinostatin as studied by 13C NMR methine relaxation at natural abundance. J Biomol NMR (1995) 0.84
Diagnostic value of transverse axial tomoscintigraphy for the detection of hepatic metastases: results on 53 examinations and comparison with other diagnostic techniques. Eur J Nucl Med (1981) 0.84
Elevated chromosome translocation frequencies in New Zealand nuclear test veterans. Cytogenet Genome Res (2008) 0.84
Sequential study of the bone marrow granulocytic progenitor cells (CFC *) in children treated by chemotherapy for non-hodgkin malignant lymphomas. Nouv Rev Fr Hematol (1979) 0.83
Dental device-associated problems: an analysis of FDA postmarket surveillance data. J Am Dent Assoc (2001) 0.83
JC human polyomavirus is associated to chromosomal instability in peripheral blood lymphocytes of Hodgkin's lymphoma patients and poor clinical outcome. Ann Oncol (2009) 0.83
Cancer incidence in French Polynesia 1985-95. Trop Med Int Health (2000) 0.83
Baseline and treatment-induced chromosomal abnormalities in peripheral blood lymphocytes of Hodgkin's lymphoma patients. Int J Radiat Oncol Biol Phys (2003) 0.83
Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med (1997) 0.82
5-Fluorouracil, doxorubicin, and cisplatin as treatment for adrenal cortical carcinoma. Cancer (1991) 0.82
Intrinsic radiosensitivity and chromosome aberration analysis using fluorescence in situ hybridization in cells of two human tumor cell lines. Radiat Res (1994) 0.82
[The lymphocyte populations in chronic lymphoid leukemia and their response to splenic irradiation]. Rev Fr Etud Clin Biol (1969) 0.82
Incubation of autologous bone marrow graft with ASTA Z 7557: comparative studies of hematological reconstitution after purged or nonpurged bone marrow transplantation. Pediatr Hematol Oncol (1987) 0.81
Radiosensitivity of human normal and tumoral thyroid cells using fluorescence in situ hybridization and clonogenic survival assay. Int J Radiat Oncol Biol Phys (1999) 0.81
Estimation of the radiation dose from radiotherapy for skin haemangiomas in childhood: the ICTA software for epidemiology. Phys Med Biol (2000) 0.81
A translocation (7;10)(q35;q21) in a differentiated papillary carcinoma of the thyroid. Cancer Genet Cytogenet (1989) 0.81
Relationship between thyrotropin stimulation and radioiodine uptake in lung metastases of differentiated thyroid carcinoma. J Clin Endocrinol Metab (1983) 0.81
In vitro medullary granulocytic progenitor (CFUc) cultures from 6 cases of granulocytopenias. Scand J Haematol (1978) 0.80
Chest computed tomography (CT) in patients with micronodular lung metastases of differentiated thyroid carcinoma. Int J Radiat Oncol Biol Phys (1985) 0.80
Intraoperative detection of pheochromocytoma with iodine-125 labelled meta-iodobenzylguanidine: a feasibility study. Eur J Nucl Med (1993) 0.80
Individual radiation therapy patient whole-body phantoms for peripheral dose evaluations: method and specific software. Phys Med Biol (2009) 0.80
Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131. J Nucl Med (1998) 0.80
Cytogenetic studies on 19 papillary thyroid carcinomas. Genes Chromosomes Cancer (1992) 0.80
Irradiated neuroblastoma in childhood as potential risk factor for subsequent thyroid tumour. Lancet (1988) 0.80
[Post-radiation nephritis. Study of the renal consequences of splenic irradiation for lymphoma]. J Radiol Electrol Med Nucl (1975) 0.79
Renal consequences of irradiation of the spleen in lymphoma patients. Br J Radiol (1979) 0.79
Acute myeloblastic leukemia after immunodepressive therapy for primary nonmalignant disease. Nouv Rev Fr Hematol Blood Cells (1976) 0.79
[Goiter with disturbances in formation of iodothyronines and the presence of abnormal iodoproteins]. Ann Endocrinol (Paris) (1971) 0.79
Octreotide scintigraphy in patients with differentiated thyroid carcinoma: contribution for patients with negative radioiodine scan. J Clin Endocrinol Metab (1996) 0.79
Thyroglobulin assay in the follow-up of patients with differentiated thyroid carcinomas: comparison of its value in patients with or without normal residual tissue. Acta Endocrinol (Copenh) (1981) 0.79
[Laparotomy in Hodgkin's disease. Evaluation of results]. Nouv Presse Med (1975) 0.79
Effect of a plaster containing DHEP and heparin in acute ankle sprains with oedema: a randomized, double-blind, placebo-controlled, clinical study. Curr Med Res Opin (2010) 0.78
Individualized phantom based on CT slices and auxological data (ICTA) for dose estimations following radiotherapy for skin haemangioma in childhood. Radiother Oncol (1998) 0.78
Incidence of haematological malignancies in French Polynesia between 1990 and 1995. Leuk Res (1999) 0.78
[Validation of biological dosimetry in patients conditioned with total body irradiation: conventional cytogenetics and in situ hybridization(FISH)]. Cancer Radiother (2001) 0.78